Symposium SB05-Emerging Bioresponsive Nanomaterials for Theranostics

This symposium aims to bring together scientists engaged in interdisciplinary research focused on disease diagnostics and therapy. It leverages nanomaterials designed to respond to specific pathologic microenvironment, such as reactive oxygen species, pH, temperature, enzymatic activity, etc., or certain stimuli, such as light, magnetic fields, ultrasound, radiation, and microwaves. Nanomaterials, characterized by variations in sizes, shapes, chemical compositions, and surface chemistry, are increasingly pertinent for imaging and therapy. Bioresponsive nanomaterials, capable of reacting to specific stimuli and environments, offer heightened sensitivity, improved efficiency, and minimized side effects. The design and synthesis of materials for imaging and therapy, particularly for complex diseases like cancer, pose significant research challenges. Nevertheless, multifunctional nanomaterials hold the potential to address these challenges. Additionally, immunotherapy has shown exceptional promise in cancer therapy. Bioresponsive nanomaterials could augment the effectiveness of immunotherapy and broaden its application to a wider range of diseases. Furthermore, the integration of artificial intelligence (AI) or machine learning (ML) technology has the potential to expedite the development of emerging bioresponsive nanomaterials for disease theranostics.

This symposium has been designed to provide an opportunity to discuss the most recent advances in bioresponsive nanomaterials, including current challenges and future directions. The topics will include the synthesis, characterization, and application of emerging and new nanomaterials in imaging, therapy, and biomedical engineering. Additionally, discussions will encompass immunotherapy and the design of nanomaterials assisted by artificial intelligence.

biomaterial magnetic properties nanoscale nucleation & growth